Therefore, the application of anti-TM4SF5 reagents or similar approaches may be promising ways to avoid the development of NAFLD, in addition to behavioral therapeutic approaches. The gene discussed is TM4SF5; the disease is metabolic dysfunction-associated steatotic liver disease.